Table 4

Prevalence of migraine before and after percutaneous PFO closure for other reasons, in per cent

Before closureAfter closure
nFollow-up (months)MigraineMigraine with auraMigraineMigraine with aura
Wilmshurst103717574330*24*
Schwerzmann 112152422172015
Post12666391816*5*
Azarbal136634530178
Reisman1416293524≈15Not reported
Giardini1513120Not reported27Not reported5*
Slavin16120304233≈14≈10
Rigatelli17101110010000
Dubiel18191382413188
Morandi191761004771*12*
Anzola2050121006664*44*
Vigna215361004366*19*
Present study60359251616*10*
  • * p<0.05.

  • 29 migraine patients who received an Amplatzer PFO Occluder were also included in the present study.